Perspective Therapeutics Earnings Forecast: Analyst Insights

1 min read | October 03, 2024 04:32 AM PDT | By Team Kalkine Media

Headlines

  • Wedbush updates earnings projections for Perspective Therapeutics
  • Company shows slight earnings improvement despite losses
  • Multiple analysts offer positive outlook on stock performance

Wedbush (NYSE:WFC) has recently provided insights into the earnings projections for Perspective Therapeutics. In a research note, it was anticipated that the company would report a quarterly loss. The consensus estimate for the company's earnings for the current fiscal year suggests a similar trend, reflecting ongoing challenges.

In their latest forecast, Wedbush estimated the upcoming quarterly earnings, along with projections extending to fiscal years beyond. Perspective Therapeutics (NYSE:CATX) previously announced its earnings, showing a small increase compared to earlier expectations.

Additionally, various equity analysts have expressed their views on Perspective Therapeutics. Oppenheimer revised its price target, while Bank of America initiated coverage, reflecting optimism about the company’s potential. Cantor Fitzgerald maintained a favorable stance, and Royal Bank of Canada adjusted its price objective but still retains a positive outlook. Truist Financial also entered coverage, underscoring confidence in the company.

With multiple analysts recognizing the company’s capabilities, Perspective Therapeutics has garnered a favorable rating from a majority of industry analysts, indicating a positive sentiment surrounding its future performance.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next